Featured Content

  • " "

    Cost Management
    Implement customized, industry-specific initiatives to revitalize performance and enhance value.
  • " "

    Artificial Intelligence
    AI can deliver significant business impact, but companies can maximize value with an end-to-end approach.
  • Build for the Future Ambient Hero

    Build for the Future
    BCG’s research reveals six key success factors and the steps companies need to take today.

The foreign brands succeeding in emerging markets are customizing their go-to-market portfolio.

John Wong is a core member of Boston Consulting Group’s Health Care practice and the chairman of the firm’s Greater China system. He previously served as the chairman of the Asia-Pacific region and on BCG’s Global Executive and Operating committees. He was named a Top 25 Consultant by Consulting magazine in 2004. 

John is an expert in the biopharmaceutical and medtech sectors and serves both global pharmaceutical and medtech companies in Asia, as well as local biopharmaceutical companies in China

Before joining BCG in 1982, John worked in R&D for Milliken Research. He specialized in modeling the non-Newtonian fluid mechanics of chemicals systems.

AREAS OF EXPERTISE

EDUCATION

  • MBA, Harvard Business School
  • MS, chemical engineering, Massachusetts Institute of Technology
  • BS, chemical engineering, first class honors, Imperial College

HONORS AND AWARDS

  • Top 25 Consultant, Consulting magazine, 2004

Publications and Videos

Competing in China’s Booming Biopharma Market - square

Competing in China’s Booming Biopharma Market

Multinational companies need to map a strategy to tap into China’s growth—and compete with increasingly innovative “homegrown” Chinese biopharma companies.
opportunity-in-crisis-for-asean-health-care-providers-rec.jpg

COVID-19: An Opportunity in Crisis for ASEAN Health Care Providers

In crisis lies opportunity. While most hospitals are struggling to weather this crisis, the likely winners are already acting to succeed in a post-COVID-19 world.
" "

中国药品市场下一个十年的“危”与“机”

中国的药品市场正在发生根本性变化，逐渐转向创新和质量。所有药企都需要重新审视自己的产品组合、研发，尤其是原研药和创新药的营销模式。
chinas-leap-manufacturing-2880x1620-tcm9-209356.jpg

China’s Next Leap in Manufacturing

Despite rising costs and trade disputes, the country’s manufacturing sector is poised for strong growth.
digital-innovation-on-the-world-stage-2880x1620-tcm9-191871.jpg

Digital Innovation on the World Stage

Global challengers are providing exciting new models for others to follow.
Digital Leadership in Emerging Markets|Hero

Digital Leadership in Emerging Markets

Even the most powerful traditional competitors need to develop digital strategies and capabilities.
meet-the-2018-global-challengers-2880x1620-tcm9-191880.jpg

Meet the 2018 Global Challengers

Digital capabilities put many global challengers in a strong position to challenge developed-market companies for leadership.
emerging-markets-a-driving-digital-force-2880x1620-tcm9-191875.jpg

Emerging Markets: A Driving Digital Force

The economic future in emerging markets looks increasingly digital.
oppt-chinese-private-health-insurance-1694x950-tcm9-63116.jpg

Opportunities Open Up in Chinese Private Health Insurance

Dissatisfaction with the public health care system is prompting many Chinese to consider alternatives. One answer is reimbursement insurance, likely to be a $60 billion market by 2020.
china-digital-hc-revolution-cvr-1694x950-tcm9-59812.jpg

China’s Digital Health-Care Revolution

Digital technology is transforming health care in China, and players including pharmaceutical and medtech companies, distributors and retailers, and payers will need to adapt.
winning-in-china-changing-medtech-1694x950-tcm9-59764.jpg

Winning in China’s Changing Medtech Market

Health care reform in China will transform the medtech market in the years ahead, forcing both multinational corporations and local companies to adapt.
new-rules-china-1694x950-tcm9-62895.jpg

New Rules for Winning in China’s Pharmaceutical Market

Powerful forces, including health care reform, are sweeping the pharmaceutical market in China, rewriting the rules for both multinational corporations and local companies.
Deep Expertise, Broad Experience